Blog
What Is Tirzepatide? How It Works and What to Know

Quick Answer
What is tirzepatide? Tirzepatide is a dual GIP and GLP-1 receptor agonist, a prescription medication that reduces appetite and lowers blood sugar. The FDA approved it as Mounjaro for type 2 diabetes in 2022 and as Zepbound for weight management in 2023. It is made by Eli Lilly and given as a weekly injection.
Key Takeaways
- What is tirzepatide? It is the first dual GIP and GLP-1 receptor agonist, made by Eli Lilly.
- The FDA approved it as Mounjaro for diabetes in 2022 and as Zepbound for weight loss in 2023.
- In the SURMOUNT-1 trial, the 15 mg dose produced about 20.9 percent mean weight loss over 72 weeks.
- In a head-to-head trial, tirzepatide led to more weight loss than semaglutide.
- Compounded tirzepatide is not FDA-approved and is prepared per individual prescription by a licensed pharmacy.
What is tirzepatide, in simple terms?
What is tirzepatide at the most basic level? Tirzepatide is a prescription medicine that copies two natural gut hormones at once, GIP and GLP-1. Those hormones help control appetite and blood sugar. By acting on both, tirzepatide produces strong effects on hunger and weight.
The drug comes from Eli Lilly. It is the first and only FDA-approved dual GIP and GLP-1 receptor agonist. According to the FDA, tirzepatide first earned approval in 2022 for type 2 diabetes.
What is tirzepatide used for?
Tirzepatide has two main approved uses, under two brand names. The FDA cleared Mounjaro for type 2 diabetes in 2022, and Zepbound for chronic weight management in 2023. In late 2024, Zepbound also gained approval for moderate to severe obstructive sleep apnea in adults with obesity.
- Type 2 diabetes, to improve blood sugar control (Mounjaro).
- Chronic weight management, for adults with obesity or related conditions (Zepbound).
- Obstructive sleep apnea, for adults with obesity (Zepbound).
How does tirzepatide work in the body?
Here the question moves from what is tirzepatide to how does tirzepatide work. The drug is a single molecule that switches on two receptors, GIP and GLP-1. Both sit in areas of the brain that regulate appetite. Tirzepatide lowers how many calories you take in, mainly by reducing hunger.
- It acts on appetite centers in the brain, so hunger and cravings drop.
- It slows how fast the stomach empties, so meals feel filling for longer.
- It helps the pancreas manage insulin and steadies blood sugar.
- The GIP action may ease nausea, which can make tirzepatide easier to tolerate.
To protect muscle while you lose fat, aim for enough daily protein. The AHC GLP-1 protein calculator gives you a target to work toward.
What are the brand names for tirzepatide?
Tirzepatide is sold under two brand names from Eli Lilly. They use the same drug substance and manufacturing, and differ in approved use, labeling, and price. Compounded tirzepatide is a separate category, covered below.
| Product | Approved use | Form | FDA status |
| Mounjaro | Type 2 diabetes | Weekly injection | Approved 2022 |
| Zepbound | Weight, sleep apnea | Weekly injection | Approved 2023 |
| Compounded tirzepatide | Per prescription | Injection | Not FDA-approved |
What is the difference between tirzepatide, Mounjaro, and Zepbound?
This is a common point of confusion. Tirzepatide is the drug. Mounjaro and Zepbound are brand names for that same drug. Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is tirzepatide approved for weight management and sleep apnea. The molecule does not change. The label, the dose range, and the price do.
How does tirzepatide compare to semaglutide?
Both reduce appetite, but they act differently. Semaglutide targets one hormone pathway, GLP-1. Tirzepatide targets two, GLP-1 and GIP. In the head-to-head SURMOUNT-5 trial, published in the New England Journal of Medicine, tirzepatide produced greater average weight loss than semaglutide, about 20.2 percent versus 13.7 percent. A provider helps decide which fits your situation.
How much weight can you lose on tirzepatide?
Results rise with the dose. In the SURMOUNT-1 trial, adults without diabetes lost more weight at higher doses over 72 weeks, compared with about 3.1 percent on placebo. These results came alongside diet and activity.
| Tirzepatide dose | Average weight loss | Pounds (approx.) |
| 5 mg | 16.0% | 35 lb |
| 10 mg | 21.4% | 49 lb |
| 15 mg | 22.5% | 52 lb |
To set a realistic pace for your own goal, map your timeline with the AHC weight loss planner.
How fast does tirzepatide work?
Tirzepatide starts at a low dose and rises slowly to limit side effects. A typical schedule begins at 2.5 mg once weekly, then steps up over about 20 weeks under provider guidance. Appetite often drops in the first four weeks.
Measurable weight loss usually builds over two to three months and continues over six to twelve months. To gauge your daily calorie needs as you go, try the AHC TDEE calculator.
How long do you stay on tirzepatide, and what if you stop?
Another part of what is tirzepatide is how long you take it. Because obesity is a chronic condition, tirzepatide is often a long-term therapy. Some people use it for a year or more. When people stop, appetite tends to return and some weight regain is common. In the SURMOUNT-4 maintenance trial, people who continued tirzepatide kept losing weight, while those switched to placebo regained about 14.8 percent.
Clinicians often suggest tapering with provider guidance, plus protein-forward eating and resistance training to protect results. A provider helps you plan the right length of treatment.
What are the side effects of tirzepatide?
Part of what is tirzepatide in practice is its side effects. Most side effects involve the gut, because tirzepatide slows digestion. In SURMOUNT-1, nausea affected about 31 percent of the 15 mg group and diarrhea about 22 percent. Most cases were mild to moderate, and about 6 percent stopped due to side effects.
- Nausea, vomiting, diarrhea, or constipation, most common when starting or raising the dose.
- Stomach pain, bloating, or burping.
- Lower appetite and feeling full quickly.
- Gallbladder problems and, rarely, pancreatitis.
The FDA label carries a boxed warning. In animal studies, tirzepatide caused thyroid C-cell tumors, and whether it does so in humans is not known. People with a personal or family history of medullary thyroid carcinoma or MEN 2 should not use it.
Who should not take tirzepatide?
Part of what is tirzepatide is knowing who should avoid it. Tirzepatide is not right for everyone. A provider screens for these situations before prescribing any form, brand or compounded.
- A personal or family history of medullary thyroid carcinoma or MEN 2.
- A known allergy to tirzepatide or any ingredient in the product.
- Pregnancy, plans to become pregnant, or breastfeeding.
- A history of pancreatitis or certain serious gastrointestinal conditions.
What is compounded tirzepatide?
Compounded tirzepatide is a version prepared by a licensed pharmacy from the active ingredient, based on a prescription for one specific patient. It is not the same as Mounjaro or Zepbound. The FDA notes that compounded drugs are not reviewed for safety, effectiveness, or quality before they reach patients.
With a brand, you get a standardized, FDA-reviewed product. With compounded tirzepatide, you rely on the licensed provider who prescribes it and the licensed pharmacy that prepares it.
Is compounded tirzepatide legal in 2026?
The rules changed recently and are still moving. Pharmacies could compound copies while tirzepatide sat on the FDA shortage list. When the shortage ended, that allowance closed. Here is the timeline.
- December 19, 2024: the FDA declared the tirzepatide shortage resolved, ending the shortage-based compounding allowance.
- Spring 2025: the enforcement grace periods for 503A pharmacies and 503B outsourcing facilities ended.
- April 30, 2026: the FDA proposed removing tirzepatide from the 503B bulk substances list, with a comment window closing June 29, 2026.
Patient-specific compounding under section 503A continues under its own framework when a licensed provider documents a clinical need. A provider decides what is appropriate, case by case.
How much does tirzepatide cost?
A practical part of what is tirzepatide is the price. Brand-name tirzepatide is expensive without insurance. List prices for Mounjaro and Zepbound have run over 1,000 dollars per month. Coverage for weight loss is uneven, so many people pay cash and look for lower-cost paths.
Alternate Health Club offers compounded tirzepatide at a flat 169 dollars per month, with no membership fees and no dose-escalation markups. Compounded semaglutide is 129 dollars per month. Access depends on provider approval after an individual evaluation.
How do you get tirzepatide?
A final part of what is tirzepatide is how to get it. Tirzepatide is prescription-only in every form. You cannot buy it over the counter. The path is straightforward, and it starts with a quick check of your numbers.
Begin with the AHC BMI calculator to see if you are in range, then take the evaluation so a licensed provider can review your history and goals.
Frequently Asked Questions
What is tirzepatide?
What is tirzepatide in one sentence? Tirzepatide is a dual GIP and GLP-1 receptor agonist, a prescription medication for type 2 diabetes and weight management, sold as Mounjaro and Zepbound.
What is tirzepatide used for?
Tirzepatide is approved for type 2 diabetes (Mounjaro), chronic weight management, and obstructive sleep apnea (Zepbound). A provider decides which use applies to you.
How does tirzepatide work?
Tirzepatide activates two gut hormone receptors, GIP and GLP-1. It slows stomach emptying and curbs appetite in the brain, which lowers calorie intake and supports weight loss.
Is tirzepatide the same as Mounjaro or Zepbound?
Tirzepatide is the active ingredient. Mounjaro is tirzepatide for diabetes, and Zepbound is tirzepatide for weight management and sleep apnea. Same drug, different brands and uses.
How much weight can you lose on tirzepatide?
Results rise with dose. In SURMOUNT-1, adults lost about 16 percent at 5 mg, 21.4 percent at 10 mg, and 22.5 percent at 15 mg over 72 weeks, alongside lifestyle changes.
Is tirzepatide better than semaglutide?
In the head-to-head SURMOUNT-5 trial, tirzepatide produced greater average weight loss than semaglutide. The right choice still depends on your health history and a provider’s judgment.
How fast does tirzepatide work?
Appetite often drops in the first four weeks. Measurable weight change builds over two to three months and continues over six to twelve months.
What are the side effects of tirzepatide?
Gastrointestinal effects lead the list: nausea, diarrhea, constipation, and stomach discomfort. The FDA label also carries a boxed warning about thyroid tumors seen in animals.
What happens when you stop tirzepatide?
Appetite usually returns and some weight regain is common. Tapering with a provider, plus protein and resistance training, can help protect results.
Is tirzepatide a GLP-1?
Tirzepatide acts on the GLP-1 pathway and also on GIP, a second gut hormone. It is often grouped with GLP-1 drugs but is technically a dual agonist.
Is tirzepatide safe?
FDA-approved tirzepatide has a known safety profile with risks on its label. Compounded tirzepatide is not FDA-approved. Discuss your history with a licensed provider.
What is compounded tirzepatide?
It is tirzepatide prepared by a licensed pharmacy from an individual prescription. Compounded tirzepatide is not FDA-approved and is not reviewed by the FDA for safety or quality.
Do you need a prescription for tirzepatide?
Yes. Tirzepatide is prescription-only in every form. A licensed provider must evaluate you first.
How long does tirzepatide stay in your system?
Tirzepatide has a half-life of about five days, which is why it is dosed once weekly. It takes several weeks to clear after the last dose.
What is tirzepatide made of?
What is tirzepatide made of? The active part is the tirzepatide molecule, a dual GIP and GLP-1 receptor agonist, combined with inactive ingredients for weekly injection.
What is tirzepatide’s success rate for weight loss?
In SURMOUNT-1, average weight loss reached about 22.5 percent at the 15 mg dose over 72 weeks, alongside diet and activity.
What is tirzepatide microdosing?
What is tirzepatide microdosing? It means using smaller amounts than standard dosing, sometimes to ease side effects or maintain weight, always under provider guidance.
What is tirzepatide’s effect on appetite?
What is tirzepatide‘s effect on appetite? It reduces hunger and cravings by acting on GIP and GLP-1 receptors in the brain and slowing stomach emptying.
How do I find out if I qualify for tirzepatide?
Take the AHC free online evaluation. A licensed U.S. provider reviews your answers and decides what is appropriate before any treatment ships.
Start with Alternate Health Club
Alternate Health Club is a LegitScript-certified telehealth platform. Want to know if a compounded GLP-1 program fits your situation? Take the free online evaluation. Independently licensed U.S. providers review every assessment, and approved treatment ships to all 50 states at flat monthly pricing, with no membership fees and no dose-escalation markups.
Medical disclaimer
This article is for educational purposes only and is not medical advice. It does not create a doctor-patient relationship. Compounded medications referenced here are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. Prescriptions are issued only by independently licensed U.S. clinicians after an individual evaluation, and providers retain full discretion to prescribe or decline treatment. Results vary by individual. Brand names belong to their respective trademark owners and are used only for educational context. Always talk with a licensed healthcare professional before starting, stopping, or changing any medication.